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PAtherosclerosis
Hypoxia, Hypoxia-Inducible Transcription
Factor, and Macrophages in Human Atherosclerotic
Plaques Are Correlated With Intraplaque Angiogenesis
Judith C. Sluimer, MSC,* Jean-Marie Gasc, PHD,§ Job L. van Wanroij, MD,† Natasja Kisters, BSC,*
Mathijs Groeneweg, MSC,* Maarten D. Sollewijn Gelpke, MSC, Jack P. Cleutjens, PHD,*
Luc H. van den Akker, MD,¶ Pierre Corvol, MD, PHD,§ Bradly G. Wouters, PHD,‡
Mat J. Daemen, MD, PHD,* Ann-Pascale J. Bijnens, PHD*
Maastricht, Oss, and Sittard, the Netherlands; and Paris, France
Objectives We sought to examine the presence of hypoxia in human carotid atherosclerosis and its association with
hypoxia-inducible transcription factor (HIF) and intraplaque angiogenesis.
Background Atherosclerotic plaques develop intraplaque angiogenesis, which is a typical feature of hypoxic tissue and ex-
pression of HIF.
Methods To examine the presence of hypoxia in atherosclerotic plaques, the hypoxia marker pimonidazole was infused
before carotid endarterectomy in 7 symptomatic patients. Also, the messenger ribonucleic acid (mRNA) and pro-
tein expression of HIF1, HIF2, HIF-responsive genes (vascular endothelial growth factor [VEGF], glucose trans-
porter [GLUT]1, GLUT3, hexokinase [HK]1, and HK2), and microvessel density were determined in a larger series
of nondiseased and atherosclerotic carotid arteries with microarray, quantitative reverse transcription polymer-
ase chain reaction, in situ hybridization, and immunohistochemistry.
Results Pimonidazole immunohistochemistry demonstrated the presence of hypoxia, especially within the macrophage-
rich center of the lesions. Hypoxia correlated with the presence of a thrombus, angiogenesis, and expression of
CD68, HIF, and VEGF. The mRNA and protein expression of HIF, its target genes, and microvessel density in-
creased from early to stable lesions, but no changes were observed between stable and ruptured lesions.
Conclusion This is the first study directly demonstrating hypoxia in advanced human atherosclerosis and its correlation with the
presence of macrophages and the expression of HIF and VEGF. Also, the HIF pathway was associated with lesion pro-
gression and angiogenesis, suggesting its involvement in the response to hypoxia and the regulation of human in-
traplaque angiogenesis. (J Am Coll Cardiol 2008;51:1258–65) © 2008 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.12.025w
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ruman atherosclerotic plaques demonstrate extensive in-
raplaque angiogenesis, which is associated with plaque
rowth and instability (1–3). However, the molecular path-
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Maastro), Research Institute Growth and Development (GROW), University of
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rance; Department of Molecular Design and Informatics, NV Organon, Oss, the
etherlands; and the ¶Department of Surgery, Maasland Hospital, Sittard, the
etherlands. The authors participate in the European Vascular Genomics Network,
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rogram for Research Priority 1 (contract LSHM-CT-2003-503254). Research was
upported in part by grants from the van Walree Fund, Royal Netherlands Academy
f Arts and Sciences, the Innovational Research Veni program of the Netherlands
rganization of Scientific Research (grant 916.046.083), and the SenterNovem
gency of the Dutch Ministry of Economic Affairs (grant TSGE3088).(
Manuscript received July 31, 2007; revised manuscript received November 20,
007, accepted December 10, 2007.ays initiating intraplaque angiogenesis in atherosclerotic
esions have not been revealed. Because angiogenesis is a
ajor consequence of hypoxic tissue, the mere presence of
ntraplaque angiogenesis suggests the existence of hypoxia
n human atherosclerosis. Evidence of hypoxia in human
ascular disease is supported by the in vivo detection of
ypoxia in macrophage regions in rabbit atherosclerosis (4)
nd the expression of several hypoxia-induced genes in
therogenesis (5). Nevertheless, hypoxia per se has not yet
een demonstrated in human atherosclerosis.
See page 1266
Two well-known sensors and mediators of the hypoxic
esponse are the hypoxia-inducible transcription factors
HIF) 1 and 2. The heterodimer protein consists of
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April 1, 2008:1258–65 Hypoxia, HIF, and Macrophages in Atherosclerosissubunits: a HIF1 subunit, which is constitutively ex-
ressed, and a HIF1 or HIF2 subunit, whose protein
evels are highly regulated by the oxygen concentration (6).
he HIF1 and -2 proteins are rapidly degraded by the
biquitin/proteasome pathway in the presence of oxygen.
pon inhibition of an HIF subunit degradation by hyp-
xia, the protein translocates to the nucleus, dimerizes with
IF1, and induces transcription of hypoxia-responsive
enes involved in angiogenesis and glucose metabolism (i.e.,
ascular endothelial growth factor [VEGF], glucose trans-
orter [GLUT]1 and GLUT3, and hexokinase [HK]1 and
K2) (6).
Although it is widely accepted that HIF expression is
ainly regulated at the protein level, quantitative and
ualitative differences exist between HIF1 and -2 mes-
enger ribonucleic acid (mRNA) expression (7). In addition,
ome studies indicate a transcriptional regulation of HIF
8,9). A possible role for HIF in atherosclerosis is supported
y the presence of intraplaque angiogenesis and the impli-
ation of several known HIF-responsive genes in athero-
clerosis, such as VEGF (5,6), endothelin-1 (6,10), and
atrix-metalloproteinase-2 (6,11). However, the associa-
ion of hypoxia and the HIF pathway with human athero-
clerosis has not yet been established. In the present study,
e tested the hypotheses that hypoxia is present in human
therosclerosis and associated with the HIF pathway and
hat the HIF pathway is associated with progression and
ngiogenesis of human atherosclerosis.
ethods
etection of hypoxia in human atherosclerosis. Hypoxia
as detected in human atherosclerotic carotid arteries with
he hypoxia marker pimonidazole hydrochloride (Hy-
oxyprobe-1, Natural Pharmacia Inc., Belmont, Massachu-
etts). The investigation was approved by an external ethics
ommittee, and written informed consent from patients was
btained. Pimonidazole (0.5 g/m2) was injected intrave-
ously 2 h before carotid endarterectomy of 7 symptomatic
atients (Table 1). Four tissue samples were consecutively
emoved: 1) arterial wall after incision of the artery; 2)
therosclerotic plaque; 3) arterial wall after removing the
laque; and 4) skin prior to wound closure.
In vivo, pimonidazole is subject to oxidative metabolism
nd resulting pimonidazole derivatives form protein ad-
ucts. Oxygen and pimonidazole compete for electron
linical Characteristics of Patients Infused With Hypoxia Marker
Table 1 Clinical Characteristics of Patients Infused With Hypox
ID # Age (yrs) Gender BMI (kg/m2) Symptoms
1 62 M 29 TIA
2 47 M 31 A. fugax
3 77 M 24 TIA
4 72 F 25 TIA
5 76 F 28 A. fugax
6 59 F 27 Minor stroke. fugax  amourosis fugax; BMI  body mass index; TIA  transient ischemic attack.ddition, accounting for the O2-
ependence of pimonidazole ad-
uct formation. Although pi-
onidazole itself may react with
eactive oxygen species (ROS),
he antipimonidazole antibody
nly recognizes hypoxia deriva-
ives. In vivo-formed pimonida-
ole adducts in hypoxic, but via-
le cells (pO2 10 mm Hg 1%
2) were detected ex vivo in for-
alin-fixed, paraffin-embedded
issue by immunohistochemistry
ith an antibody that only de-
ects hypoxia-derivatives of pi-
onidazole.
low cytometry experiments
ith pimonidazole. Human
HP-1 cells (ATCC, TIB-202,
anassas, Virginia) were differentiated into macrophages
Online Appendix) and exposed to an oxygen gradient (0%,
.2%, 1%, 5%, and 21% O2; MACS VA500 micro-
erophilic workstation, Don Whitley Scientific, Shipley,
nited Kingdom), 100 mol/l H2O2 (Merck, Darmstadt,
ermany) or a combination of 0.2% O2 and H2O2 for 15
in, 1 h, and 4 h, all in triplicate. Cells were incubated with
nd without pimonidazole (100 mol/l) and stained with
uorescein isothiocyanate-conjugated antipimonidazole
pimo-FITC, 1:1,000; Chemicon, Temecula, Calfifornia).
imonidazole was quantified in 1  104 cells (FACS
alibur) using the excitation geomean at 530 nm
CellQuest, BD-Science, San Jose, California).
xpression of HIF pathway in human atherosclerosis. A
otal of 10 human caval veins, 15 nondiseased pulmonary or
ammary arteries, and 72 atherosclerotic carotid arteries
ere obtained from patients undergoing vascular surgery
Departments of Surgery, Sittard and Maastricht, the Neth-
rlands) or at autopsy (Department of Pathology, University
ospital Maastricht, Maastricht, the Netherlands) to study
he expression pattern of the HIF pathway. Tissue collec-
ion was performed in agreement with the “Dutch code of
onduct for Observational Research with personal data
2004) and tissue (2001).”
The mean age was 69  11.5 years, and 51% (n  52) of
atients were male. Samples were processed and classified as
arker
enosis (%) Diabetes Hypertension Statins Smoking
80–99 Type 2   
80–99 —   
80–99 —   
80–99 —   
80–99 —   
80–99 —   
Abbreviations
and Acronyms
EC  endothelial cell
GLUT  glucose
transporter
HIF  hypoxia-inducible
transcription factor
HK  hexokinase
KiEC  proliferating,
Ki-67 endothelial cell
qRT-PCR  quantitative
reverse transcription-
polymerase chain reaction
ROS  reactive oxygen
species
VEGF  vascular
endothelial growth factoria M
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Hypoxia, HIF, and Macrophages in Atherosclerosis April 1, 2008:1258–65escribed previously (12,13) and subdivided as nondiseased,
arly (intimal thickening or pathological intimal thicken-
ng), stable (thin or thick fibrous cap atheroma), or
hrombus-containing (luminal thrombus or intraplaque
emorrhage) lesions.
mmunohistochemistry. Sections were stained with pri-
ary antibodies against pimonidazole, HIF1, HIF2,
EGF, GLUT1, GLUT3, HK1, CD68, Ki-67, CD31,
D34, and activated caspase 3 (Online Table 1), with
nrelated immunoglobulin G1 or without the primary
ntibody (negative controls).
Immunoreactivity in the plaques was scored by one
bserver (J.C.S) as follows: (0  none; 1  mild; 2 
oderate; 3  extensive). Hematoxylin and eosin-stained
ections were used to score fibrosis, thrombus (0  absent,
 present), and angiogenesis (0  none; 1  mild; 2 
oderate; 3  extensive).
n situ hybridization. Ribonucleic acid expression of HIF1
nd HIF2 was evaluated in 7-m sections of 3 carotid
rteries with early, stable, or thrombus-containing lesions by in
itu hybridization as previously described (14,15).
icroarray. Ribonucleic acid was isolated from 9 early and 6
dvanced stable carotid lesions collected at autopsy (12).
amples were individually hybridized to HGU133 2.0 Plus
rrays (n  17, Affymetrix, Santa Clara, California) according
o the manufacturer’s instructions (Online Appendix). The
rray represents 54,000 probe sets and 47,000 transcripts
including 38,000 genes). The error model of Rosetta Re-
olver (Rosetta Biosoftware, Seattle, Washington) was used to
etermine fold changes between early and stable atherosclerotic
esions, significant when p 0.05. Ingenuity pathway analysis
Ingenuity Systems, Mountain View, California) was per-
ormed on genes with a p value of 0.01.
uantitative reverse transcription-polymerase chain re-
ction (qRT-PCR). A comparison of mRNA expression
as made between early (n  5) and stable lesions (n  5)
rom autopsy and between stable (n  4) and thrombus-
ontaining lesions (n  5) from surgery. Quantitative
T-PCR for HIF1, HIF2, VEGF, GLUT1, GLUT3,
K1, HK2, glyceraldehyde-3-phosphate dehydrogenase,
nd 18S ribosomal ribonucleic acid (Applied Biosystems,
oster City, California) were performed as previously de-
cribed (12).
laque angiogenesis. A computerized morphometric anal-
sis (Leica QWin V3, Cambridge, United Kingdom) of
laque microvessel density (total count/total plaque area)
as performed on 6 carotids with intimal thickening and 6
table and 5 thrombus-containing lesions of post-mortem
arotid arteries. A double-staining with Ki-67 and
D31CD34 was used to quantify proliferating Ki-67
ndothelial cells (KiECs).
tatistical analysis. All data are presented as mean 
EM. Quantitative RT-PCR, immunoreactivity, and mean
essel diameter were compared between groups with a
ann-Whitney rank-sum test, and Spearman’s  correla-
ion coefficient was calculated for ordinal immunohisto-hemistry variables (version 12.0, SPSS Inc., Chicago,
llinois). Bonferroni’s multiple testing correction was per-
ormed, and results were considered significantly different
hen p  0.05.
esults
ypoxia present in human carotid atherosclerosis. The
resence of hypoxia in human carotid atherosclerosis was
emonstrated by pimonidazole immunoreactivity in all pa-
ients injected with pimonidazole (Fig. 1). Hypoxia was
resent throughout the plaque (n  27 of 31 segments) of
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Figure 1 Hypoxia Detection With
Pimonidazole in Human Carotid Endarterectomy
(A) Hypoxia (pimonidazole immunoreactivity) is present in the center of an
advanced human carotid atherosclerotic plaque, but not in the media. Inset shows
hematoxylin and eosin staining. (B) A serial section of panel A shows that CD68-
positive macrophages colocalize with hypoxia. (C) Macrophage regions of the
lesion from panel A show extensive hypoxia, whereas the cap shows mild or no
hypoxia. (D) Hypoxia is present in CD68-positive macrophages (inset) at 20 to 30
m from the lumen. (E) Hypoxia is absent in CD68-positive macrophages (inset)
of a plaque shoulder segment (pathological intimal thickening). (F) Hypoxia is
present in an atherosclerotic plaque segment with intimal thickening, more specifi-
cally in a few CD68-positive macrophages (inset). (G) The immunoreactivity score
of hypoxia (open bars) and CD68 (solid bars) is increased in stable and ruptured
atherosclerotic lesions versus early lesions (*p  0.05 vs. early; stable vs. rup-
tured is not significant). L  lumen.
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April 1, 2008:1258–65 Hypoxia, HIF, and Macrophages in Atherosclerosispatients containing advanced atheromas with intraplaque
emorrhage or a luminal thrombus. In 2 patients, hypoxia
as present in only 1 segment per plaque (n 2 of 12). One
esion was a stable fibrocalcified plaque with no or minor
nflammation, and the other showed almost undetectable
ntraplaque hemorrhage (data not shown). Because the use
f pimonidazole was previously shown to detect hypoxia in
ormal skin (16), staining of a skin biopsy confirmed that
he pimonidazole injection was successful in all patients
Online Fig. 1). Antibody specificity was confirmed by a
omplete lack of immunoreactivity in 5 patients without
imonidazole administration (Online Fig. 1).
Hypoxia immunoreactivity colocalized with CD68-
ositive macrophage foam cells (Figs. 1B, 2A, and 2B) but
as also mildly present in smooth muscle cells. Pimonida-
ole is only metabolized in viable cells, explaining the lack of
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Figure 2 Hypoxia Colocalizes With CD68, HIF, and VEGF
(A) Hypoxia detected by pimonidazole immunoreactivity in human carotid ath-
erosclerosis. Serial sections show colocalization with CD68-positive macro-
phages (B), HIF1 (C), and VEGF (D). (E) The immunoreactivity score of
CD68, HIF1, and VEGF is increased when hypoxia is present (solid bars) ver-
sus absent (open bars) in human carotid atherosclerosis (*p  0.05). HIF 
hypoxia-inducible transcription factor; VEGF  vascular endothelial growth
factor.
pearman Correlation Coefficients of Hypoxia Immunoreactivity Wi
Table 2 Spearman Correlation Coefficients of Hypoxia Immunor
Thrombus Fibrosis CD68
Spearman’s  0.60* 0.07 0.70*Bonferroni corrected p  0.05.
HIF  hypoxia-inducible transcription factor; VEGF  vascular endothelial growth factor.taining in necrotic or acellular areas. Hypoxia strongly
orrelated with CD68, angiogenesis and the presence of a
hrombus, but not with the presence of fibrosis (Table 2) or
poptosis (data not shown). Two hypoxic gradients were
bserved as illustrated by Figure 3. Cross-sectionally, hyp-
xia was very strong in macrophage clusters surrounding the
laque core, but was absent in a 100- to 250-m rim
ordering the lumen (Figs. 1A and 1B) and in the media
Figs. 1A and 1C). However, some isolated macrophages
ocated 20 to 30 m from the lumen were hypoxic (Fig.
D). Longitudinally, hypoxia was most intense in parts of
he plaque containing an advanced atheroma with a throm-
us and inflammation (Figs. 1A and 1G) and mostly absent
n shoulder regions with (pathological) intimal thickening
espite inflammatory infiltration (Figs. 1E and 1G). How-
ver, in a minority of shoulder segments with (pathological)
ntimal thickening hypoxia was present, but only in macro-
hages (Fig. 1F). Hypoxia was present in all longitudinal parts
f the plaque, predominantly in macrophages, although not all
acrophages were hypoxic (Table 3, Fig. 1G).
ypoxia detection is not influenced by surgery-induced
schemia or ROS. To exclude that pimonidazole immu-
oreactivity in the atherosclerotic plaque was the result of
urgery-induced ischemia, arterial wall segments were col-
ected at 2 time points: directly after incision of the carotid
rtery and directly after excision of the plaque. Pimonida-
ole immunoreactivity in these 2 pieces was not different
Figs. 4A and 4B), suggesting that hypoxia and pimonida-
ole adducts were already present in the plaques before
urgery.
Although the antipimonidazole antibody only recog-
izes hypoxia derivatives, pimonidazole itself may react
ith ROS. Hypoxia specificity was confirmed in human
HP-1 macrophages exposed to hypoxia and/or H2O2.
xposure to H2O2 induced intracellular antioxidant activity
ithout influencing cell viability (data not shown). Only
ypoxic exposure up to 1% O2 showed pimonidazole-
mmunoreactive cells (data not shown). Immunoreactivity
f combined exposure to hypoxia and H2O2 was similar to
ingle hypoxic exposure, showing that the concentration of
imonidazole available for hypoxia detection was not lim-
ted by H2O2-derivatives of pimonidazole (Fig. 4C).
olocalization of hypoxia, HIF, and macrophages. Hyp-
xia typically stabilizes HIF protein, and the colocalization
nd correlation of hypoxia with HIF1 (Fig. 2C), HIF2
data not shown), and VEGF (Fig. 2D) suggests this also
ccurs in atherosclerosis (Table 3). Analogous to hypoxia
mmunoreactivity, nuclear HIF1 (Figs. 5C and 5D) and
aracteristics of Carotid Atherosclerosis
ivity With Characteristics of Carotid Atherosclerosis
Angiogenesis HIF1 HIF2 VEGF
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Hypoxia, HIF, and Macrophages in Atherosclerosis April 1, 2008:1258–65IF2 (Figs. 5G to 5H) immunoreactivity and mRNA
Figs. 6B and 6C) were predominantly detected at sites of
nflammation. Strong correlations of CD68 immunoreac-
ivity were found with HIF1 (  0.70, p  0.007) and
IF2 (  0.63, p  0.02).
ypoxia-inducible transcription factor pathway mRNA
nd protein are associated with progression from early to
dvanced atherosclerosis. Microarray, qRT-PCR, and
emiquantitative immunohistochemistry showed that
RNA and protein expression of HIF1, HIF2, and
heir targets increased from early to advanced human
therosclerosis. Microarray pathway analysis revealed the
ignificant differential expression of canonical pathways
HIF signaling” (7 of 70 genes, p  0.02) and “VEGF
ignaling” (15 of 90 genes, p  0.02) between early and
dvanced human atherosclerosis. At the single gene level,
IF1, VEGF, GLUT3, and HK2 mRNA were signif-
cantly up-regulated between early and stable lesions:
.4-, 1.8-, 2.0-, and 2.3-fold, respectively (Fig. 7A).
icroarray results were validated with qRT-PCR with
he use of a different set of patient samples, explaining
hat only VEGF mRNA was significantly upregulated on
RT-PCR (Fig. 7B). However, the same trends were
hown using microarray and qRT-PCR. On the other
and, protein expression levels of HIF and HIF-
esponsive genes were significantly increased with pro-
ression of atherosclerosis from early to advanced
laques, except for HK1 (Fig. 8A). The lack of corre-
ponding GLUT1 and GLUT3 mRNA and protein levels
ay be explained by previous observations of increased
ranslation efficiency and protein stability, respectively. No
ignificant differences of HIF and HIF-responsive genes
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Figure 3 Schematic Illustration of Hypoxia in Atherosclerosis
Illustration of the presence of hypoxia (blue) in a longitudinal and cross-sectional
representation of atherogenesis. a.wall  arterial wall; nc  necrotic core; th  th
ercentage of Segmentshowi g Hypoxia or CD68 Immunoreactivity
Table 3 Percentage of SegmentsShowing Hypoxia or CD68 Immunoreactivity
Lesion type (n) Hypoxia, % (n) CD68, % (n)
Early (8) 13 (1) 50 (4)
Stable (14) 71 (10) 93 (13)Thrombus (21) 90 (19) 95 (20)ere seen between the 2 advanced lesion types, stable or
hrombus-containing lesions, either on the mRNA level or
n the protein level (Figs. 7C and 8A).
ngiogenesis in human carotid atherosclerosis paralleled
IF and VEGF expression. Intraplaque microvessel den-
ity increased from early to advanced lesions (p  0.01) but
as not different between stable or thrombus-containing
esions (Fig. 8E). In addition, strong correlations were
ound between microvessel density and HIF1 (  0.80,
 0.001), HIF2 (  0.77, p  0.001), and VEGF ( 
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Figure 4 Hypoxia Detection in Arterial Wall and Human THP-1
Macrophages After Hypoxic and/or H2O2 Exposure
(A) Hypoxia (pimonidazole immunoreactivity) is almost absent in the arterial
wall collected right after carotid incision, as well as right after excision of the
atherosclerotic plaque (B). Insets show origin of magnification. (C) Pimonida-
zole was detected in human THP-1 macrophages in 0.2% O2 with fluorescence-
activated cell sorting analysis (green bars), but was undetectable in 21% O2
(open bars) or after H2O2 stimulus (black bars). No significant differences
were found between single O2 and O2  H2O2 exposure (blue bars). *p 
0.05 versus 21% O2. Pimo-FITC  fluorescein isothiocyanate-conjugated
antipimonidazole.rombu
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April 1, 2008:1258–65 Hypoxia, HIF, and Macrophages in Atherosclerosis.66, p  0.01). Although abundant proliferating macro-
hages and smooth muscle cells were observed, hardly any
iECs were detected in plaque microvessels: 3 KiECs in 5
hrombus-containing lesions. However, microvessel ECs
ere not apoptotic either, as indicated by the absence of
ctivated-caspase 3 (data not shown).
iscussion
his study convincingly demonstrates the direct presence of
enuine hypoxia in the macrophage-rich center of human
arotid atherosclerosis using the hypoxia marker pimonida-
ole. Hypoxia strongly correlated with CD68-positive mac-
ophages, which is similar to previous studies in rabbit
therosclerosis (4), but also with the presence of angiogen-
A
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C L
H
G
L
FB
L
L
Figure 5 Immunoreactivity of HIF Pathway in
Nondiseased and Atherosclerotic Carotid Artery
Nuclear staining of HIF1 (A to D) and HIF2 (E to H) is absent in the human
mammary artery (A and E, respectively) and increased from early (B and F,
respectively) to advanced carotid lesions (C and G, respectively). Macrophages
in advanced lesions demonstrated strong HIF1 (D) and HIF2 (H) expression.
Nuclear immunoreactivity (functional protein levels) of HIF1 and HIF2 are
similar. Abbreviations as in Figures 1 and 2.sis and a thrombus. The latter effect is most likely mediatedy macrophages, as these infiltrate into the thrombus,
esolving the clot.
Hypoxia detection was not due to an artifact of surgery or
OS. First, not all cells nor every part of the plaque was
ypoxic. Hypoxia was mild or absent in the media and close
o the main artery lumen, although smooth muscle cells are
ssumed to be metabolically active. Second, hypoxia detec-
ion was similar between vascular specimens collected either
mmediately after carotid clamping or just before clamp
elease, arguing that hypoxia was present in the plaque prior
o clamping. In addition, macrophage in vitro data con-
rmed the hypoxia-selective detection of pimonidazole by
ts antibody. As previously shown (17), the antibody did not
ross-react with ROS-derivatives of pimonidazole, nor was
he pimonidazole dose a limiting factor.
Hypoxia occurs when oxygen supply is decreased and/or
emand is increased. Hypoxia of the vessel wall could arise
hen the intimal thickness exceeds the maximal oxygen
iffusion distance of100 to 250 m (18), reducing oxygen
upply. In fact, the intimal thickness of the advanced,
arotid lesions analyzed was significantly greater (1,500 
50 m) than the oxygen diffusion distance, and in most
esions a hypoxia-negative rim of 100 to 250 m borders the
umen. Hypoxia may also develop from an increased oxygen
emand, resulting from the high oxygen demand of meta-
olically active inflammatory cells (19). Hypoxia is indeed
ypically present in macrophage foam cells, but not all
acrophages are hypoxic. However, some subluminal (20-
o 30-m) foam cells were already hypoxic, despite their
ocation well within the oxygen diffusion distance. Thus, the
ypoxia threshold seems mostly dependent on the inflam-
Figure 6 Localization of HIF1 and HIF2
mRNA in Advanced Carotid Lesion
(A) Bright field images of human carotid with an advanced atherosclerotic
plaque corresponding to dark field images (B and C). Expression of HIF1 (B)
and HIF2 (C) messenger ribonucleic acid (mRNA) (white dots) was observed in
macrophages surrounding the core and in the shoulder regions of advanced
atherosclerosis. (D) No signal is observed using sense probes (negative con-
trol) for HIF1. Abbreviations as in Figures 1 and 2.
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Hypoxia, HIF, and Macrophages in Atherosclerosis April 1, 2008:1258–65atory micro-environment, although our observations sup-
ort a (minor) contribution for a decreased oxygen supply.
As hypoxic cells typically activate HIF, we studied
hether HIF was present in hypoxic atherosclerosis. Al-
hough several nonhypoxic stimuli are known to induce HIF
rotein, such as lipopolysacharide (20) and angiotensin II
8), hypoxia is the most obvious stimulator of HIF-induced
ngiogenesis to restore oxygen load. Indeed, in human
therosclerosis hypoxia colocalized and correlated with HIF,
EGF, and intraplaque angiogenesis. Recent studies
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Figure 7 Relative Expression Levels of HIF Pathway mRNA
(A) The expression ratio determined between 9 early and 6 stable lesions by
microarray analysis was significantly different for HIF1, VEGF, GLUT3, and
HK2. *p  0.01; **p  0.001; ***p  0.00001. (B) Quantitative reverse
transcription polymerase chain reaction was used to compare the expression
ratio between 5 early and 5 stable lesions collected at autopsy (*p  0.05)
and (C) between 4 stable and 5 thrombus-containing lesions collected at sur-
gery. GLUT  glucose transporter; HK  hexokinase; mRNA  messenger ribo-
nucleic acid; other abbreviations as in Figure 2.howed no association of HIF immunoreactivity with cor-nary intraplaque angiogenesis (21) and an inverse correla-
ion with carotid and femoral intraplaque angiogenesis (22).
hese results are unexpected, considering the established
ositive correlation between HIF and angiogenesis in
umors (6), in rabbit atherosclerosis in vivo, and in our
tudy (23). Nonetheless, the strong correlation of HIF
mmunoreactivity with inflammation and VEGF has
een confirmed (22).
We hypothesize that hypoxia in macrophages stimulates
IF and angiogenesis in the progression of human athero-
clerosis. In addition to a proangiogenic effect, hypoxia in
acrophages has been described to increase cytokine pro-
uction (19), low-density lipoprotein oxidation (24), and
ipid loading (25) in vitro, processes that are all associated
ith the development of macrophage foam cells, a lipid
nd/or necrotic core, and hence, with destabilization of a
laque (1). Thus, we speculate that hypoxic macrophages
ontribute to atherosclerotic plaque instability.
tudy limitations. However, because of the cross-
ectional, observational study design, it remains unclear at
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Figure 8 Semiquantification of HIF Pathway
Immunoreactivity in Carotid Atherosclerosis
(A) Immunoreactivity of HIF pathway proteins was significantly increased from
early (green bars, n  5) to stable lesions (white bars, n  5) for HIF1,
HIF2, VEGF, GLUT1, and GLUT3 but similar in stable and thrombus-containing
lesions (blue bars, n  5). *p  0.05 versus early; **p  0.01 versus early.
(B) Macrophages in advanced lesions demonstrated strong immunoreactivity of
HIF-responsive genes: VEGF (B), GLUT3 (C), and HK1 (D). (E) Microvessel
density was determined in 6 human carotid arteries with early (intimal thicken-
ing), 6 stable, or 5 thrombus-containing atherosclerotic lesions. *p  0.01 ver-
sus early. L  lumen; other abbreviations as in Figures 2 and 7.
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April 1, 2008:1258–65 Hypoxia, HIF, and Macrophages in Atherosclerosishat plaque stage hypoxia first occurs and whether hypoxia
s a cause or consequence of atherogenesis. The HIF
xpression study precludes establishing an association be-
ween hypoxia and atherogenesis, as upstream stimuli other
han hypoxia may explain HIF stabilization in atheroscle-
osis. Other limitations of this study are the lack of clinical
haracteristics in the HIF expression study and of quanti-
ative protein data (e.g., western blot).
onclusions
his study is the first to directly demonstrate hypoxia in
uman advanced atherosclerotic lesions. Hypoxia correlated
ith the presence of macrophages, angiogenesis, thrombus,
nd the expression of HIF and VEGF. Also, the HIF
athway and microvessel density were associated with lesion
rogression and angiogenesis, suggesting the involvement of
he HIF pathway in the response to hypoxia and the
egulation of human intraplaque angiogenesis.
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